Relationship Between Components of Metabolic Syndrome and Polysomnographic Findings in Obstructive Sleep Apnea

Ozol, Duygu; Turkay, Cansel; Kasapoglu, Benan; Karamanlı, Harun; Yıldırım, Zeki
February 2011
Metabolic Syndrome & Related Disorders;Feb2011, Vol. 9 Issue 1, p13
Academic Journal
Aims: Obstructive sleep apnea/hypoapnea syndrome (OSAHS) and metabolic syndrome are both growing health concerns, owing to the worldwide obesity epidemic. This study evaluates the potential association between the parameters of metabolic syndrome and OSAHS. Methods: A total of 125 consecutive patients undergoing complete full night polysomnography were included. Insulin resistance (IR) was estimated using the homeostasis model assessment (HOMA), and metabolic syndrme was diagnosed according to the National Cholesterol Education Program (NCEP) criteria. Results: The prevelance of metabolic syndrome was 23.8% among patients with OSAHS. We found that IR, age, weight, hypertension, and metabolic syndrome prevalence increased significantly with severity of OSAHS. There were no differences between groups for lipid panels including total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Subjects with metabolic syndrome had significantly lowest desaturation value (76% vs. 81%) desaturation (76% vs. 81%, P = 0.003), lower mean nocturnal oxygen saturation (89.9% vs. 92.3%, P < 0.00.1), higher apnea-hypopnea index (AHI) (40.9 vs. 17, P < 0.001), and higher oxygen desaturation index (38 vs. 17, P = 0.002). Lowest desaturation and mean nocturnal oxygen saturation were significantly lower in subjects with IR (76% vs. 85%, P = 0.004 and 90.4% vs. 93.0%, P = 0.02). In multivariate analysis, the percent of time below 90% saturation [%T < 90]) ( P = 0.04) was independently associated with IR. Conclusions: Our results suggested that metabolic syndrome prevalence increased with severity of OSAHS and vice versa. Nocturnal hypoxic episodes in OSAHS patients could be a risk factor for developing hypertension and IR.


Related Articles

  • HNF4α is a Crucial Modulator of the Cholesterol-Dependent Regulation of NPC1L1. Yuki Iwayanagi; Tappei Takada; Hiroshi Suzuki // Pharmaceutical Research;May2008, Vol. 25 Issue 5, p1134 

    Abstract Purpose  Niemann-Pick C1-like 1 (NPC1L1) has been identified as a target of ezetimibe and found to be responsible for intestinal cholesterol absorption. Although, it was recently demonstrated that sterol responsive element binding protein 2 (SREBP2) is responsible for...

  • Do we need lipid clinics? Shifting the balance between secondary and primary care. Stuart, W; Smellie, A // Annals of Clinical Biochemistry;Nov2005, Vol. 42 Issue 6, p463 

    Background: Increasing activity in cholesterol lowering is placing increasing demands on lipid clinics to be able to cope with the increase in demand. A combination of interventions has been used to improve laboratory testing, focus interpretative results and provide educational and advisory...

  • False negative results in the Roche assay for HDL-cholesterol. Bakker, Andries J; Zijlstra, Appie; Leemhuis, Marten P // Annals of Clinical Biochemistry;Sep2003, Vol. 40 Issue 5, p572 

    Measurement of HDL-cholesterol is important in the risk evaluation of cardiovascular disease. Recently, we encountered a 61-year-old man with a negative result for HDL-cholesterol using the Roche assay. Further analysis revealed that this patient had a monoclonal Ig type IgMκ, with an...

  • Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in São Paulo compared to Natives and Japanese-Brazilians in Japan. Andiara Schwingel; Wojtek Chodzko-Zajko; Ryosuke Shigematsu; Christopher Erb; Simone Souza; Tomoaki Matsuo; Suely Marie // European Journal of Epidemiology;Jan2007, Vol. 22 Issue 1, p33 

    Abstract??Blood lipid levels are determined by a combination of genetic and environmental factors. Higher than average values of high-density lipoprotein cholesterol (HDL-cholesterol) have been observed in people of Japanese ethnicity. The aim of this study was to investigate whether Japanese...

  • Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. Vincent Soriano; Pilar García-Gasco; Eugenia Vispo; Andrés Ruiz-Sancho; Francisco Blanco; Luz Martín-Carbonero; Sonia Rodríguez-Novoa; Judit Morello; Carmen de Mendoza; Pablo Rivas; Pablo Barreiro; Juan González-Lahoz // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61 Issue 1, p200 

    : Background Atazanavir seems to be a protease inhibitor (PI) with a more favourable metabolic profile. Information regarding the potential benefit of replacing lopinavir/ritonavir by atazanavir in HIV-infected patients with prolonged viral suppression is scarce. If proved, this strategy could...

  • Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect. Andrew Campbell; Samuel Chan // Journal of Bioenergetics & Biomembranes;Jun2008, Vol. 40 Issue 3, p193 

    Abstract  Normal cells of aerobic organisms synthesize the energy they require in the form of ATP via the process of oxidative phosphorylation. This complex system resides in the mitochondria of cells and utilizes oxygen to produce a majority of cellular ATP. However, in most tumors,...

  • Comparison of lipid and non-lipid markers of atherosclerosis in arterial versus venous blood. Palmer, Bruce; Watson, Linley E; Riggs, Mark W; Lawrence, Mark; Baisden, Clinton E; McNeal, Catherine J; Macfarlane, Ronald D // Annals of Clinical Biochemistry;May2003, Vol. 40 Issue 3, p286 

    Background: Early studies have suggested that there may be differences in the concentration of lipoprotein particles and their associated apolipoproteins in arterial and venous blood and that this gradient might explain a proclivity to develop atherosclerotic lesions. The aim of this study was...

  • Cholesterol precursors and facial clefting. Porter, Forbes D. // Journal of Clinical Investigation;Sep2006, Vol. 116 Issue 9, p2322 

    Inborn errors of cholesterol synthesis cause human malformation syndromes, including Smith-Lemli-Opitz syndrome, lathosterolosis, desmosterolosis, X-linked dominant chondrodysplasia punctata type 2, and congenital hemidysplasia with ichthyosiform erythroderma and limb defects. Because adequate...

  • Primary Prevention and Coronary Heart Disease: The Economic Benefits of Lowering Serum Cholesterol. Oster, Gerry; Epstein, Arnold M. // American Journal of Public Health;Jun86, Vol. 76 Issue 6, p647 

    We examined the expected economic benefits of cholesterol lowering for adult men with significant elevations of total serum cholesterol (above 260 mg/dl), incorporating estimates of direct benefits from anticipated reductions in lifetime expenditures for medical care, and estimates of indirect...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics